SCHEMBL5773806

SCHEMBL5773806

Cc1ccc(-c2cnc(C(=O)CCCNC(=O)[CH]CC(F)(F)CCC(N)=O)o2)s1

nearest known ligand 0.40

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FAAH O00519 11/20 0.40
CES1 P23141 2/20 0.34
HDAC1 Q13547 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3873883 0.83 FAAH (0.33) FAAH
SCHEMBL5775485 0.69 SMN1; SMN2 (0.35)
SCHEMBL3873948 0.67
SCHEMBL5777473 0.63
SCHEMBL3873891 0.62 PI4KB (0.33) FAAH
SCHEMBL3871717 0.56 SMN1; SMN2 (0.34)
SCHEMBL10053489 0.55 CA12 (0.61)
SCHEMBL9378748 0.54 DAO (0.50)
SCHEMBL6167127 0.53 TAAR1 (0.48)
SCHEMBL9068363 0.52 HDAC1 (0.51) HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682524-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2006-07-26 EP claimed
WO-2005040142-A9 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMA INC (US) 2005-06-09 WO claimed
WO-2005040142-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2005-05-06 WO claimed